RiverFront Investment Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10M Buy
77,843
+23,849
+44% +$2.79M 0.13% 84
2026
Q1
$6.49M Buy
53,994
+29,789
+123% +$3.44M 0.1% 87
2025
Q4
$2.55M Buy
24,205
+1,068
+5% +$100K 0.04% 112
2025
Q3
$1.94M Buy
23,137
+3,032
+15% +$250K 0.03% 121
2025
Q2
$1.59M Buy
20,105
+3,204
+19% +$255K 0.03% 122
2025
Q1
$1.52M Buy
16,901
+3,812
+29% +$356K 0.03% 117
2024
Q4
$1.3M Buy
13,089
+925
+8% +$95.4K 0.03% 105
2024
Q3
$1.38M Buy
12,164
+1,535
+14% +$182K 0.03% 91
2024
Q2
$1.32M Buy
10,629
+39
+0.4% +$5.02K 0.04% 82
2024
Q1
$1.4M Sell
10,590
-203
-2% -$25K 0.04% 78
2023
Q4
$1.18M Buy
+10,793
New +$1.12M 0.04% 84
2021
Q3
Sell
-3,710
Closed -$289K 123
2021
Q2
$289K Buy
+3,710
New +$276K 0.01% 94

Other funds holding MRK

RiverFront Investment Group's MRK Position: Q2 2026 in Review

RiverFront Investment Group increased its Merck (MRK) stake by 44% in Q2 2026, buying an estimated $2.79M and bringing the position to 77,843 shares worth $10M. The position accounts for 0.13% of the portfolio, ranked #84.

RiverFront Investment Group first reported a position in MRK in Q2 2021 and has held it in 12 quarters since. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • RiverFront Investment Group held 77,843 shares of Merck worth $10M as of Q2 2026.
  • RiverFront Investment Group bought 23,849 Merck shares in Q2 2026, an estimated $2.79M.
  • Merck made up 0.13% of RiverFront Investment Group's portfolio in Q2 2026, its #84 holding.
  • RiverFront Investment Group first reported a position in Merck in Q2 2021 and has held it in 12 quarters since.
  • 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on RiverFront Investment Group's 13F filing for Q2 2026, filed 29 Jul 2026.